CTLA4 and hepatocellular carcinoma: Recently, the immune checkpoint inhibitor (ICI) combination with PD-1 antibody and cytotoxic T-lymphocyte–associated protein-4 (CTLA-4) antibody has been proved to be effective for advanced HCC.